The goals of CIPRA are to provide long-term support to developing countries to 1) plan and implement a comprehensive HIV/AIDS prevention and treatment research agenda relevant to their populations and 2) enhance the infrastructure necessary to conduct such research. The program provides flexibility for applicants with different levels of research capabilities.
A data analysis center that compiles data from DAIDS-funded international research use by DAIDS-funded investigators to answer population level questions on HIV variants and resistance, HIV pathogenesis in different settings, success of highly active antiretroviral therapy (HAART), treated history of HIV in different populations, success of prevention strategies, or vaccine related questions. The center also fosters collaborations with other large databases.
An ongoing prospective study of the natural and treated histories of HIV-1 infection in 6,973 homosexual and bisexual men at sites located in Baltimore, Chicago, Pittsburgh, and Los Angeles.
A multi-institute initiative (Eunice Kennedy Shriver National Institute of Child Health and Human Development and NIAID) investigating the long-term safety of fetal/infant exposure to antiretroviral drugs, as well as the effects of perinatally acquired HIV infection on adolescent development.
A research program focusing on HIV pathogenesis in women, including gender differences in immunology, pharmacology, response to therapy, complications of therapy, and immunological, virological, genetic, and behavioral aspects of transmission.
A cohort study established in 1993 and currently following 2,404 HIV-infected and uninfected women to examine the natural history of HIV among women in an era of combination treatments referred to as HAART.
back to top
Last Updated January 03, 2010